Blau Farmacêutica Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Millions BRL. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	2,222	2,496	2,337	2,916	4,681	6,530
Market Cap Growth	0.85%	6.84%	-19.87%	-37.70%	-28.32%	-
Enterprise Value	2,190	2,715	2,442	3,041	4,231	6,028
Last Close Price	9.62	10.81	9.35	11.29	17.76	23.83
PE Ratio	7.53	8.46	10.76	11.67	12.88	20.08
Forward PE	6.54	8.14	8.13	12.65	11.36	15.20
PS Ratio	1.31	1.47	1.33	2.12	3.33	4.78
PB Ratio	0.99	1.11	1.09	1.46	2.58	3.99
P/TBV Ratio	1.34	1.51	1.19	1.60	2.82	4.39
P/FCF Ratio	77.14	86.67	6.41	40.99	160.06	1100.43
P/OCF Ratio	7.64	8.58	4.61	13.22	27.23	42.37
PEG Ratio	0.40	0.54	0.45	4.22	0.58	0.75
EV/Sales Ratio	1.29	1.60	1.39	2.22	3.01	4.41
EV/EBITDA Ratio	5.17	6.41	6.44	6.36	9.01	12.70
EV/EBIT Ratio	6.18	7.66	7.21	6.78	9.36	13.20
EV/FCF Ratio	76.03	94.27	6.70	42.74	144.69	1015.90
Debt / Equity Ratio	0.27	0.27	0.26	0.31	0.17	0.23
Debt / EBITDA Ratio	1.41	1.41	1.45	1.26	0.66	0.79
Debt / FCF Ratio	20.80	20.80	1.53	8.55	10.66	63.11
Net Debt / Equity Ratio	-0.01	-0.01	0.03	0.10	-0.18	-0.33
Net Debt / EBITDA Ratio	-0.04	-0.04	0.17	0.42	-0.71	-1.15
Net Debt / FCF Ratio	-0.55	-0.55	0.18	2.83	-11.35	-92.40
Asset Turnover	0.48	0.48	0.54	0.49	0.58	0.76
Inventory Turnover	1.57	1.57	1.78	1.47	1.50	1.88
Quick Ratio	1.57	1.57	1.99	2.75	2.99	3.70
Current Ratio	2.47	2.47	3.12	4.63	4.52	4.95
Return on Equity (ROE)	13.47%	13.47%	10.30%	12.98%	20.88%	34.89%
Return on Assets (ROA)	6.29%	6.29%	6.55%	10.09%	11.71%	15.85%
Return on Invested Capital (ROIC)	11.26%	12.15%	11.23%	18.03%	27.05%	34.35%
Return on Capital Employed (ROCE)	12.40%	12.40%	11.80%	16.50%	21.30%	23.00%
Earnings Yield	13.27%	11.82%	9.30%	8.57%	7.76%	4.98%
FCF Yield	1.30%	1.15%	15.60%	2.44%	0.63%	0.09%
Dividend Yield	3.69%	-	-	2.61%	2.79%	-
Payout Ratio	-	27.80%	25.83%	26.48%	37.30%	32.02%
Buyback Yield / Dilution	-	-	-	0.08%	0.87%	-13.84%
Total Shareholder Return	3.69%	-	-	2.70%	3.66%	-13.84%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.